These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9363046)

  • 1. Placebo response in generalized anxiety: its effect on the outcome of clinical trials.
    Schweizer E; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():30-8. PubMed ID: 9363046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of new anxiolytic drugs (author's transl)].
    Boulenger JP
    Nouv Presse Med; 1982 May; 11(22):1687-94. PubMed ID: 6124934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D; Hill C; Lenderking W; Williams V; Morlock R
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1988 May; 49(5):189-92. PubMed ID: 2896666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
    Sheehan DV
    J Clin Psychiatry; 2001; 62 Suppl 19():26-31. PubMed ID: 11577788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anxiolytic SC 48274 (AGN 2979; BTG 1501) in generalized anxiety disorder.
    Gittos MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):i-ii. PubMed ID: 7863012
    [No Abstract]   [Full Text] [Related]  

  • 10. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing onset of treatment benefit in depression and anxiety: conceptual considerations.
    Laska EM; Mallinckrodt CH; Mundt JC; Leber P; Vaccarino AL; Kalali AH; Greist JH
    J Clin Psychiatry; 2009 Aug; 70(8):1138-45. PubMed ID: 19758524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 13. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
    Pollack MH; Endicott J; Liebowitz M; Russell J; Detke M; Spann M; Ball S; Swindle R
    J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide rates in short-term randomized controlled trials of newer antidepressants.
    Hammad TA; Laughren TP; Racoosin JA
    J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo--a research review.
    Solomon K; Hart R
    J Clin Psychiatry; 1978 Nov; 39(11):823-31. PubMed ID: 31354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-week trial with diazepam: some clinical observations.
    Rickels K; Downing RW; Case GW; Csanalosi I; Chung H; Winokur A; Gingrich RL
    J Clin Psychiatry; 1985 Nov; 46(11):470-4. PubMed ID: 3902806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.